Microbiome: Clinical Trials

5 trials for Microbiome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 unknown, 1 withdrawn. 5 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Recruiting 3, Unknown 1, Withdrawn 1
Phase 13Recruiting 2, Withdrawn 1

Follow Microbiome: new trials by email Literature Review of Microbiome trials Research Report on Microbiome

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessing the Safety of an IGY Supplement on the Gut Microbiome
IgY supplement, Placebo - Healthy, Microbiome
Phase 1 / Phase 2WithdrawnNimble Science Ltd.2026-01-012026-09-30
Oral Changes With Caloric and no Caloric Sweeteners
Stevioside, Sucrose, Natural water - pH, Microbiome
Phase 1 / Phase 2RecruitingHospital Infantil de Mexico Federico Gomez522025-08-012025-10-09
Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
THC, CBD - HIV, Cannabis
Phase 2RecruitingUniversity of California, San Diego902023-09-012026-05-01
Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis
Lyophilized fecal microbiota transplantation capsules, Placebo capsules, A. soehngenii - Non Alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease
Phase 2UnknownAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)482023-03-172024-08-27
Microbial Restoration in Inflammatory Bowel Diseases
Antibiotics, Dietician designed diet, FMT - Fecal Microbiota Transplantation, Crohn Disease
Phase 1 / Phase 2RecruitingSt Vincent's Hospital Melbourne1202022-05-012025-02-26

Narrower conditions

Crohn Disease (1)  ·  Dental Plaque (1)  ·  Inflammatory Bowel Diseases (1)  ·  Marijuana Abuse (1)  ·  Neuroinflammatory Diseases (1)  ·  Non-alcoholic Fatty Liver Disease (1)

Broader conditions

Digestive System Diseases (2)  ·  Chemically-Induced Disorders (1)  ·  Dental Deposits (1)  ·  Fatty Liver (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Inflammation (1)  ·  Intestinal Diseases (1)  ·  Liver Diseases (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Stomatognathic Diseases (1)  ·  Substance-Related Disorders (1)

Interventions

Anti-Bacterial Agents (1)  ·  Cannabidiol (1)  ·  Dronabinol (1)  ·  Natural Childbirth (1)  ·  Sucrose (1)  ·  fructooligosaccharide (1)  ·  stevioside (1)

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Hospital Infantil de Mexico Federico Gomez (1)  ·  Nimble Science Ltd. (1)  ·  St Vincent's Hospital Melbourne (1)  ·  University of California, San Diego (1)

Countries

Australia (1)  ·  Canada (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  United States (1)

Top investigators

A.G. Holleboom, MD, PhD (1)  ·  Carolina Barajas, MsC (1)  ·  Michael A Kamm, MD (1)  ·  Ronald J Ellis, MD, PhD (1)

Results publications

PMID 39788762, PMID 40254304